| Bioactivity | AEF0117 a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). AEF0117 plays an important role in Cannabis use disorder (CUD)[1]. |
| Target | cannabinoid receptor 1 (CB1-SSi) |
| Name | AEF0117 |
| CAS | 1610878-71-1 |
| Formula | C29H40O3 |
| Molar Mass | 436.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Margaret Haney, et al. Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nat Med. 2023 Jun;29(6):1487-1499. |
AEF0117
CAS: 1610878-71-1 F: C29H40O3 W: 436.63
AEF0117 a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). AEF0117 plays an important role in Canna
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.